Archives
- 2026-10
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
Biotin (Vitamin B7) for STING Assay Design
2026-09-07
Biotin and Vitamin B7 are more than metabolic cofactors or labeling handles. This article explains how to use biotin chemistry to build interpretable STING and antiviral assays without confusing molecular capture with pathway activation.
Drug Response Metrics in Cancer In Vitro
2026-09-07
Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable readouts of anticancer activity. Its central practical contribution is a framework for separating growth inhibition from cell killing, improving interpretation of drug-response experiments and apoptosis-focused studies.
Latrunculin B: Actin Dynamics Workflow Guide
2026-09-05
Latrunculin B provides a transient way to interrupt actin filament assembly, making it useful for time-resolved cytoskeletal organization studies rather than long exposures. This guide combines practical dosing, imaging controls, and a reference-study case in which actin disruption did not block grass carp reovirus entry.
Hypoxia and Immunometabolism in Tumors
2026-09-04
The 2025 Cancer Letters review by Wu and colleagues presents tumor hypoxia as an ecosystem-level driver that links metabolic reprogramming, nutrient competition, immune dysfunction, and immunosuppressive microenvironment formation. Its practical value lies in integrating oxygen biology with immune-cell metabolism and identifying experimental and therapeutic strategies that account for this bidirectional interaction.
Hyaluronic Acid Sodium Salt in siRNA Workflows
2026-09-04
Hyaluronic acid sodium salt provides a practical high-molecular-weight matrix material for nanoparticle coating, extracellular matrix modeling, and immune-cell assays. This guide translates a preclinical TDRD9-siRNA study into reproducible formulation, cell-based, organoid, and troubleshooting workflows.
BAF53a, EMT, and Glioma Invasion: Study Analysis
2026-09-03
Meng et al. identify BAF53a as a candidate independent prognostic biomarker in glioma and connect its expression to increased proliferation, motility, invasion, and EMT-associated marker changes. The study combines patient-tissue analysis with gain- and loss-of-function experiments in U87 cells, providing a mechanistic basis for further validation rather than definitive clinical translation.
Bazedoxifene: Reliable ER Assay Workflows
2026-09-03
Learn how Bazedoxifene (SKU A3232) can be integrated into estrogen receptor, viability, and proliferation experiments without confusing receptor antagonism with nonspecific cytotoxicity. This scenario-driven guide covers controls, solvent compatibility, protocol planning, interpretation, and practical supplier selection.
Gastrin I: Designing Translational GI Assays
2026-09-02
Discover how human Gastrin I peptide can be used as a compartment-aware perturbation tool across gastric signaling and human intestinal organoid workflows. This article translates recent hiPSC-organoid advances into practical assay design, controls, and interpretation strategies.
Tp47, PKM2, and Inflammatory Senescence
2026-09-02
The reference study identifies a mechanistic link between the Treponema pallidum protein Tp47, PKM2-dependent metabolic reprogramming, and inflammatory senescence in macrophages. Its findings suggest that glycolysis, lactate signaling, EIF2AK2 phosphorylation, and NLRP3-associated pyroptosis cooperate to produce a senescence-like inflammatory state relevant to syphilis pathogenesis.
T-5224 Induces Ferroptosis in Myeloma via PI3K/AKT
2026-09-01
The 2024 Heliyon study identifies ferroptosis as a previously underexplored mechanism of T-5224-mediated killing in multiple myeloma cells. By combining ferroptosis rescue experiments with PI3K/AKT pathway analysis, the work provides a mechanistic framework for evaluating AP-1 inhibition alongside bortezomib in preclinical myeloma research.
PP 2 (AG 1879) for Src Signaling Workflows
2026-09-01
PP 2 (AG 1879) provides a practical way to interrogate Lck, Fyn, and broader Src-family signaling in cancer, immune, and vascular experiments. This guide links biochemical selectivity to cell-based workflow design, dose interpretation, and troubleshooting for proliferation, invasion, phosphorylation, and contractility assays.
ARCA EGFP mRNA (5-moUTP) Workflow Guide
2026-08-31
Build a faster, more reproducible fluorescence-based transfection control with a capped, modified, polyadenylated reporter mRNA. This guide connects product handling, mammalian-cell assay design, storage science, and troubleshooting so EGFP signal becomes a quantitative workflow readout rather than a simple yes-or-no endpoint.
Entamoeba Prx Activates Macrophage Autophagy
2026-08-31
The reference study identifies Entamoeba histolytica peroxiredoxin as a parasite-derived stimulus that activates autophagy and cytotoxicity in macrophages. Its central advance is the connection of this response to the TLR4–TRIF pathway and localization of activity to the protein’s C-terminal 100 amino acids, providing a mechanistic link between parasite antioxidant biology and host innate immunity.
Carfilzomib: A Mechanistic Assay Framework
2026-08-30
Carfilzomib and PR-171 provide a powerful model for studying irreversible proteasome inhibition in cancer research. This article goes beyond standard protocols to connect proteostasis failure with ER stress, apoptosis, paraptosis, ferroptosis, and evidence-based assay design.
Angiotensin Peptides and SARS-CoV-2 Spike Binding
2026-08-29
Oliveira and colleagues show that naturally occurring angiotensin fragments can increase SARS-CoV-2 spike-protein binding to host receptors, with the strongest effects observed for selected shorter and N-terminally truncated peptides. The work connects renin–angiotensin signaling with viral-entry biochemistry while emphasizing that receptor-binding assays do not by themselves establish clinical effects or infection enhancement in vivo.
8443 records 6/563 page Previous Next First page 上5页 678910 下5页 Last page